Key result
Late-onset cardiac tamponade following COVID-19 presented with hemorrhagic pericardial fluid in four cases, with three patients surviving after pericardiocentesis and anti-inflammatory treatment.
Why the study?
Cardiac tamponade is a rare presentation in COVID-19 that can occur during the acute phase or develop subsequently as a new condition secondary to the disease.
Case Report (n=4)
Hemorrhagic cardiac tamponade can occur as a late, immune-mediated complication of COVID-19, requiring pericardiocentesis and anti-inflammatory therapy.
Late tamponade may occur after COVID-19 recovery; leaves open its incidence, causality, and need for surveillance.
Cardiac tamponade is a rare presentation in patients with COVID-19, which may be induced by the associated exacerbated inflammatory response. The onset of cardiac tamponade may be concomitant with the acute phase of the disease or may develop subsequently as a new health condition secondary to the disease. We report four cases of cardiac tamponade that occurred late after the acute phase of the disease. One of them may be considered a post-acute complication of the disease, and three of them may be classified as a new health condition induced by COVID-19. Only two cases had a history of severe respiratory distress due to COVID-19. In all four cases, pericardiocentesis was imposed, and surprisingly, in every case, hemorrhagic fluid was evacuated. In this case, series, immune-mediated etiology is supported by histopathological results, where the main identified feature was fibrous pericarditis with inflammatory infiltrate. Only one patient included in this report died, and three of them were discharged after anti-inflammatory treatment was initiated.
No takes yet. Share an insight, caveat, or question.
Ungureanu et al. (2022) conducted a case report in Cardiac tamponade in COVID-19 recovery phase (n=4). COVID-19 was evaluated on Clinical presentation and outcome. Late-onset cardiac tamponade following COVID-19 presented with hemorrhagic pericardial fluid in four cases, with three patients surviving after pericardiocentesis and anti-inflammatory treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: